Eventide Asset Management »

Alkermes shares owned by Eventide Asset Management

Quarter-by-quarter ownership of Alkermes (ALKS) shares owned by Eventide Asset Management from 13F filings

Historical chart of Eventide Asset Management investment in Alkermes

Tip: Access up to 7 years of quarterly data

All positions including Alkermes held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alkermes by Eventide Asset Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $18M 562k 31.30

More positions owned by Eventide Asset Management

Guardant Health (GH)
Mirum Pharmaceuticals (MIRM)
Xometry Class A Com (XMTR)
Trane Technologies SHS (TT)
Insmed Com Par $.01 (INSM)
Lam Research Corp Com New (LRCX)
Irhythm Technologies (IRTC)
Ge Vernova (GEV)
Scholar Rock Hldg Corp (SRRK)
Beta Bionics (BBNX)
Argenx Se Sponsored Adr (ARGX)
Roper Industries (ROP)
Vistra Energy (VST)
Axsome Therapeutics (AXSM)
Toast Cl A (TOST)

View all positions for Eventide Asset Management

Top funds holding Alkermes

BlackRock
Vanguard Group
State Street Corporation
Baker Bros. Advisors
Renaissance Technologies
American Century Companies
Geode Capital Management
Jpmorgan Chase & Co
Dimensional Fund Advisors
Commodore Capital
PRIMECAP Management Company
Holocene Advisors
venBio Select Advisor
Nuveen
Charles Schwab Investment Management

View all funds holding Alkermes